Orcid
Google scholar
Position 🏥
Discipline: OncologyFunction: Professeur des Universités – Praticien Hospitalier (PU-PH); Full ProfessorLaboratory: Director of the Laboratory of Detection of Rare Circulating Human – LCCRH, Department of Pathology and Onco-Biology, University Medical Center of Montpellier – IURC, 641, avenue du Doyen Gaston Giraud, 34093 Montpellier Cedex 5 & CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.Phone: +33 4 11 75 99 31 / +33 6 88 80 06 74 (Mobile)Fax: +33 4 67 33 52 81
Academic Qualifications 🎓
2023: University Diploma in Medical Education and Communication2012: Habilitation (University of Montpellier, France)1995/98: PhD obtained on 25th November 1998 (University Louis Pasteur Strasbourg, France)1994/95: Master 2 in Molecular and Cellular Biology (Prof Jules Hoffmann, Nobel prize – ULP Strasbourg, France)
Professional Career Development 🚀
2023-24: Full Professor at the University of Montpellier2010-23: Maître de Conférences – Praticien Hospitalier (UMC and University of Montpellier)1999-2009: Post-doctorant (2 years) then researcher (9 years) at the UMC of Montpellier2022-2026: Visiting Professor at the University of Hamburg, Germany2021-24: Top 25 best researchers at the CHU of Montpellier2020-24: Work-package leader of the European Liquid Biopsy Society (ELBS)2020-23: Consultant for Menarini as an expert in the liquid biopsy field
Key Achievements and Honors 🏆
2016: Active Member of the European Society of Medical Oncology (ESMO)2013-18: Active Member of Pilot committee of the Pole of Cancer Research ‘SIRIC’ – Colon cancer axis2013: Creation and President of the Association « BIODETECT »2006 & 2002: Patents for innovative cancer detection technologies2021: International Liquid Biopsy Society (ISLB) Award for Lifetime Achievement2022: Prestigious Alexandr Savchuk Award
Key Publications 📚
h-index: 58i10-index: 113Citations: 16,738Notable Publications:”Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.” Br J Cancer. 2023″Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.” J Clin Oncol. 2023″Liquid Biopsy: From Discovery to Clinical Application.” Cancer Discovery 2021
Teaching Activity 🎓
Experience: Over 15 years of teaching in Oncology at the Faculties of Medicine and Sciences, University of MontpellierInternational Teaching: Bari (Italy), Beirut (Lebanon), Zürich (Switzerland), Aarhus (Denmark)Supervision: 20 theses, 9 Master 2, and 10 Master 1 students since 2016Publications: 14 education book chapters and reviews
Short Biography ✨
Professor Catherine Alix-Panabières earned her PhD in 1998 from the University Louis Pasteur in Strasbourg, France. She has made significant strides in the field of oncology, particularly in the optimization of techniques for detecting and characterizing viable circulating tumor cells (CTCs). Notably, she co-coined the term ‘Liquid Biopsy’ and has received numerous awards for her contributions to cancer research. As the director of the Laboratory of Rare Human Circulating Cells (LCCRH), she continues to advance the field with innovative research and international collaborations.Her notable achievements include patents for cancer detection technologies, recognition from prestigious institutions such as the French Academy of Medicine, and significant contributions to the global understanding and application of liquid biopsy techniques in cancer research. Her work has been widely published and cited, reflecting her impact on the field of oncology.